It is important to emphasize that there is currently no FDA-approved indication for GLP-1 receptor agonists in the treatment of alcohol use disorder (AUD)
Tirzepatide often causes mild nausea, bloating, or an acidic feeling as the body gets used to the medication
OZEMPIC AND WEGOVY WEIGHT LOSS DRUGS COULD HELP REDUCE ALCOHOL USE DISORDER SYMPTOMS, STUDY SUGGESTS "Secondarily, it is available in several different forms, which can cause confusion," Amirshahi noted
But we need a new way to address chronic disease
In 2016, 650 million people were obese and in 2020, 39 million children under the age of 5 were already overweight or obese ( Current guidelines for the treatment of diabetes and obesity recommend a step-wise approach starting with lifestyle interventions aimed at body weight loss, an increase in physical activity, and additional measures for healthier choices in everyday decisions and habits
Key Terms material transfer agreement regulatory pre-clinical medical glp-1 medical research & development technical human clinical medical AI-generated analysis